B

BRAIN Biotech AG

161 employees

BRAIN provides biodiversity-based solutions for applications in the chemical, pharmaceutical, cosmetics and food industries.

Investor insights

Sectors invested in

Health Care4
Biotechnology4
Medical3
Biopharma3
Recombinant Enzymes1
Chemical1
Asymmetric Synthesis1
Chiral Chemicals1
Fine Chemicals1
Industrial Biocatalysis1
APIs1
Process Development1
Contract R&D1
Enzyme Technology1
Scale-up1
Enantioselective Catalysts1

Funding rounds participated in

$17M sweet spot round size

Most of their 4 investments are in rounds between $13M and $21M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
skincare
alternative proteins
natural food ingredients
precise fermentation
nutrition
urban mining
biocatalysts
probiotics
health
enzymes
battery recycling
protein engineering
Chemical
industrial biotechnology
green chemistry
genome editing
bioeconomy
CRISPR
microbial producer strains
green mining

Date founded

1993

Investments made

S

SolasCure raised $13M on March 27, 2023

Investors: Seneca Partners Limited, Wealth Club Ltd and BRAIN Biotech AG

S

SolasCure raised $21M on August 9, 2021

Investors: EVA pharma, Seneca Partners Limited, Bionova Capital, Development Bank of Wales and BRAIN Biotech AG

S

SolasCure raised undisclosed on August 20, 2018

Investors: BRAIN Biotech AG

E

Enzymicals AG raised undisclosed on July 14, 2010

Investors: BRAIN Biotech AG

FAQ